Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 6 days agoPatel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
More rare cancers being diagnosed after the pandemic
Becker’s Hospital Review· 7 days agoSince the 1960s, scientists have estimated that 15% to 20% of all cancers originate from infectious agents, such as HPV, Epstein-Barr and hepatitis B. It's ...
Oregon to receive $15 million in settlement over baby powder lawsuit
Oregon Capital Chronicle via Yahoo News· 1 day agoOregon will receive $15 million from Johnson & Johnson to settle allegations that the pharmaceutical...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 6 days agoThe study is evaluating the safety, tolerability and efficacy of tobevibart and investigational...
CMDHD launches new hepatitis C treatment program
Midland Daily News· 2 days agoCentral Michigan District Health Department launched a new hepatitis C treatment program, aimed at providing accessible and effective treatment to individuals in the community ...
These Are The 5 Biggest Early Warning Signs Of Liver Damage
BuzzFeed via Yahoo News· 3 days agoDouglas Weine, a gastroenterologist at Hackensack Meridian Health Center. Liver conditions include...
Can statins help prevent cancer? New study offers clues
MedicalNewsToday via AOL· 4 days agoA recent study found that using the statin pitavastatin may assist in blocking a particular...
ARUP blood services said updated donation guidelines help donors and patients
KSL TV Utah· 6 days agoThe organization is the sole provider of blood to the University of Utah and Huntsman Cancer...
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with...
KSAN - KLST San Angelo· 2 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related ...
Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide...
Morningstar· 7 days agoGilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA - Phase 2b Data Presented at EASL and Published in NEJM Show Potential for Bulevirtide 10 mg
